Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, Initial Review

---
identifier: "/us/fr/2011-8658"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "2011-8658"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, Initial Review"
positive_law: false
currency: "2011-04-12"
last_updated: "2011-04-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-8658"
document_type: "notice"
publication_date: "2011-04-12"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "76 FR 20355"
fr_volume: 76
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, Initial Review

The meeting announced below concerns “Public Health Research for the Prevention of Complications of Bleeding,” FOA DD11-009, initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

*Time and Date:* 10 a.m.-5 p.m., May 19, 2011 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the initial review, discussion, and evaluation of applications received in response to “Public Health Research for the Prevention of Complications of Bleeding,” FOA DD11-009, initial review.

*Contact Person for More Information:* Michael Dalmat, Dr.PH., Scientific Review Officer, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, Georgia 30341, *Telephone:* (770) 488-6423, E-mail: *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: April 5, 2011.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.